Physician profile
Brandon Ryan Carney
NPI 1093292278
$3,270.02
in general payments reported to CMS, 2019-2025
31 companies · $726 in 2025
The $726 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $205 · 2022: $504 · 2023: $976 · 2024: $860 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,561.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $679.23 | 2022-2025 | Repatha, Evenity, Prolia |
| Lilly USA, LLC | $413.41 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $413.27 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals Lp | $271.89 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $195.65 | 2021-2025 | |
| Pfizer INC. | $185.60 | 2022-2025 | |
| Glaxosmithkline, LLC. | $143.14 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Radius Health, INC. | $132.83 | 2021-2023 | Tymlos |
| Exact Sciences Corporation | $115.82 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.10 | 2022-2024 | Jardiance |
| Biohaven Pharmaceutical Holding Company Ltd. | $64.58 | 2022 | |
| Sumitomo Pharma America, INC. | $63.65 | 2024 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $62.98 | 2025 | |
| Astellas Pharma US INC | $51.84 | 2023-2025 | Veozah |
| Cequr Corporation | $50.73 | 2023 | Cequr Simplicity |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $47.62 | 2022-2023 | |
| Irhythm Technologies, INC. | $30.97 | 2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $30.78 | 2024 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $29.41 | 2024 | Minimed 780g |
| Si-Bone, INC. | $28.44 | 2023 | |
| Rhythm Pharmaceuticals, INC. | $23.40 | 2024 | Imcivree |
| Novartis Pharmaceuticals Corporation | $18.59 | 2024 | |
| Ibsa Pharma INC. | $18.52 | 2022 | |
| Harmony Biosciences LLC | $18.18 | 2023 | Wakix |
| Corcept Therapeutics | $17.41 | 2023 | Korlym |
| Daiichi Sankyo INC. | $16.62 | 2023 | Injectafer |
| Kiniksa Pharmaceuticals International, Plc | $16.25 | 2024 | Arcalyst |
| Mannkind Corporation | $15.50 | 2023 | Afrezza |
| Seqirus USA INC | $14.58 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Janssen Pharmaceuticals, INC | $13.85 | 2023 | Xarelto |
| Lifescan, INC. | $13.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Carney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.